ReP USP - Resultado da busca

Artigo de periodico
Matrix metalloproteinases and arterial hypertension: Role of oxidative stress and nitric oxide in vascular functional and structural alterations (2021)
Prado, Alejandro F.; Batista, Rose Inês Matos ; Tanus-Santos, José Eduardo ; Gerlach, Raquel Fernanda
Source: Biomolecules. Unidades: FMRP, FORP
Subjects: METALOPROTEINASES, HIPERTENSÃO, ESTRESSE OXIDATIVO, ÓXIDO NÍTRICO, FISIOPATOLOGIA, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRADO, Alejandro F. et al. Matrix metalloproteinases and arterial hypertension: Role of oxidative stress and nitric oxide in vascular functional and structural alterations. Biomolecules, v. 11, n. 4, p. 1-17, 2021Tradução . . Disponível em: https://doi.org/10.3390/biom11040585. Acesso em: 16 nov. 2024.
APA
Prado, A. F., Batista, R. I. M., Tanus-Santos, J. E., & Gerlach, R. F. (2021). Matrix metalloproteinases and arterial hypertension: Role of oxidative stress and nitric oxide in vascular functional and structural alterations. Biomolecules, 11( 4), 1-17. doi:10.3390/biom11040585
NLM
Prado AF, Batista RIM, Tanus-Santos JE, Gerlach RF. Matrix metalloproteinases and arterial hypertension: Role of oxidative stress and nitric oxide in vascular functional and structural alterations [Internet]. Biomolecules. 2021 ; 11( 4): 1-17.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/biom11040585
Vancouver
Prado AF, Batista RIM, Tanus-Santos JE, Gerlach RF. Matrix metalloproteinases and arterial hypertension: Role of oxidative stress and nitric oxide in vascular functional and structural alterations [Internet]. Biomolecules. 2021 ; 11( 4): 1-17.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/biom11040585
Artigo de periodico
Nitrite treatment downregulates vascular MMP-2 activity and inhibits vascular remodeling in hypertension independently of its antihypertensive effects (2019)
Rizzi, Elen; Amaral, Jefferson Henrich; Guimarães, Danielle Aparecida; Conde-Tella, Sandra de Oliveira; Pinheiro, Lucas Cézar ; Gerlach, Raquel Fernanda; Castro, Michele Mazzaron de; Tanus-Santos, José Eduardo
Source: Free Radical Biology and Medicine. Unidades: FMRP, EERP, FORP
Subjects: NITRITOS, ESTRESSE OXIDATIVO, HIPERTENSÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIZZI, Elen et al. Nitrite treatment downregulates vascular MMP-2 activity and inhibits vascular remodeling in hypertension independently of its antihypertensive effects. Free Radical Biology and Medicine, v. 130, p. 234-243, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.freeradbiomed.2018.11.002. Acesso em: 16 nov. 2024.
APA
Rizzi, E., Amaral, J. H., Guimarães, D. A., Conde-Tella, S. de O., Pinheiro, L. C., Gerlach, R. F., et al. (2019). Nitrite treatment downregulates vascular MMP-2 activity and inhibits vascular remodeling in hypertension independently of its antihypertensive effects. Free Radical Biology and Medicine, 130, 234-243. doi:10.1016/j.freeradbiomed.2018.11.002
NLM
Rizzi E, Amaral JH, Guimarães DA, Conde-Tella S de O, Pinheiro LC, Gerlach RF, Castro MM de, Tanus-Santos JE. Nitrite treatment downregulates vascular MMP-2 activity and inhibits vascular remodeling in hypertension independently of its antihypertensive effects [Internet]. Free Radical Biology and Medicine. 2019 ; 130 234-243.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.freeradbiomed.2018.11.002
Vancouver
Rizzi E, Amaral JH, Guimarães DA, Conde-Tella S de O, Pinheiro LC, Gerlach RF, Castro MM de, Tanus-Santos JE. Nitrite treatment downregulates vascular MMP-2 activity and inhibits vascular remodeling in hypertension independently of its antihypertensive effects [Internet]. Free Radical Biology and Medicine. 2019 ; 130 234-243.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.freeradbiomed.2018.11.002
Artigo de periodico
Nitrite exerts antioxidant effects, inhibits the mTOR pathway and reverses hypertension-induced cardiac hypertrophy (2018)
Guimarães, Danielle A.; Passos, Madla A. dos; Rizzi, Elen; Pinheiro, Lucas C.; Amaral, Jefferson H.; Gerlach, Raquel Fernanda; Castro, Michele Mazzaron de; Tanus-Santos, José Eduardo
Source: Free Radical Biology and Medicine. Unidades: FORP, FMRP
Subjects: ANTIOXIDANTES, HIPERTENSÃO, HIPERTROFIA VENTRICULAR ESQUERDA, NITRATOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUIMARÃES, Danielle A. et al. Nitrite exerts antioxidant effects, inhibits the mTOR pathway and reverses hypertension-induced cardiac hypertrophy. Free Radical Biology and Medicine, v. 120, p. 25-32, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.freeradbiomed.2018.03.006. Acesso em: 16 nov. 2024.
APA
Guimarães, D. A., Passos, M. A. dos, Rizzi, E., Pinheiro, L. C., Amaral, J. H., Gerlach, R. F., et al. (2018). Nitrite exerts antioxidant effects, inhibits the mTOR pathway and reverses hypertension-induced cardiac hypertrophy. Free Radical Biology and Medicine, 120, 25-32. doi:10.1016/j.freeradbiomed.2018.03.006
NLM
Guimarães DA, Passos MA dos, Rizzi E, Pinheiro LC, Amaral JH, Gerlach RF, Castro MM de, Tanus-Santos JE. Nitrite exerts antioxidant effects, inhibits the mTOR pathway and reverses hypertension-induced cardiac hypertrophy [Internet]. Free Radical Biology and Medicine. 2018 ; 120 25-32.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.freeradbiomed.2018.03.006
Vancouver
Guimarães DA, Passos MA dos, Rizzi E, Pinheiro LC, Amaral JH, Gerlach RF, Castro MM de, Tanus-Santos JE. Nitrite exerts antioxidant effects, inhibits the mTOR pathway and reverses hypertension-induced cardiac hypertrophy [Internet]. Free Radical Biology and Medicine. 2018 ; 120 25-32.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.freeradbiomed.2018.03.006
Artigo de periodico
Atorvastatin and sildenafil decrease vascular TGF-β levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension (2015)
Guimarães, Danielle A.; Rizzi, Ellen; Ceron, Carla S.; Martins-Oliveira, Alisson; Gerlach, Raquel Fernanda; Shiva, Sruti; Tanus-Santos, José Eduardo
Source: Redox Biology. Unidades: FMRP, FORP
Subjects: HIPERTENSÃO, ÓXIDO NÍTRICO, METALOPROTEINASES, FÁRMACOS (SISTEMA CARDIOVASCULAR)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUIMARÃES, Danielle A. et al. Atorvastatin and sildenafil decrease vascular TGF-β levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension. Redox Biology, v. 6, p. 386-395, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.redox.2015.08.017. Acesso em: 16 nov. 2024.
APA
Guimarães, D. A., Rizzi, E., Ceron, C. S., Martins-Oliveira, A., Gerlach, R. F., Shiva, S., & Tanus-Santos, J. E. (2015). Atorvastatin and sildenafil decrease vascular TGF-β levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension. Redox Biology, 6, 386-395. doi:10.1016/j.redox.2015.08.017
NLM
Guimarães DA, Rizzi E, Ceron CS, Martins-Oliveira A, Gerlach RF, Shiva S, Tanus-Santos JE. Atorvastatin and sildenafil decrease vascular TGF-β levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension [Internet]. Redox Biology. 2015 ; 6 386-395.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.redox.2015.08.017
Vancouver
Guimarães DA, Rizzi E, Ceron CS, Martins-Oliveira A, Gerlach RF, Shiva S, Tanus-Santos JE. Atorvastatin and sildenafil decrease vascular TGF-β levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension [Internet]. Redox Biology. 2015 ; 6 386-395.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.redox.2015.08.017
Artigo de periodico
The nuclear factor kappaB inhibitor pyrrolidine dithiocarbamate prevents cardiac remodelling and matrix metalloproteinase-2 up-regulation in renovascular hypertension (2015)
Cau, Stefany B. A.; Guimarães, Danielle Aparecida; Rizzi, Elen; Ceron, Carla S.; Gerlach, Raquel Fernanda; Tanus-Santos, José Eduardo
Source: Basic and Clinical Pharmacology and Toxicology. Unidades: FMRP, FORP
Subjects: HIPERTENSÃO, METALOPROTEINASES, RECEPTORES IMUNOLÓGICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAU, Stefany B. A. et al. The nuclear factor kappaB inhibitor pyrrolidine dithiocarbamate prevents cardiac remodelling and matrix metalloproteinase-2 up-regulation in renovascular hypertension. Basic and Clinical Pharmacology and Toxicology, v. 117, n. 4, p. 234-241, 2015Tradução . . Disponível em: https://doi.org/10.1111/bcpt.12400. Acesso em: 16 nov. 2024.
APA
Cau, S. B. A., Guimarães, D. A., Rizzi, E., Ceron, C. S., Gerlach, R. F., & Tanus-Santos, J. E. (2015). The nuclear factor kappaB inhibitor pyrrolidine dithiocarbamate prevents cardiac remodelling and matrix metalloproteinase-2 up-regulation in renovascular hypertension. Basic and Clinical Pharmacology and Toxicology, 117( 4), 234-241. doi:10.1111/bcpt.12400
NLM
Cau SBA, Guimarães DA, Rizzi E, Ceron CS, Gerlach RF, Tanus-Santos JE. The nuclear factor kappaB inhibitor pyrrolidine dithiocarbamate prevents cardiac remodelling and matrix metalloproteinase-2 up-regulation in renovascular hypertension [Internet]. Basic and Clinical Pharmacology and Toxicology. 2015 ; 117( 4): 234-241.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/bcpt.12400
Vancouver
Cau SBA, Guimarães DA, Rizzi E, Ceron CS, Gerlach RF, Tanus-Santos JE. The nuclear factor kappaB inhibitor pyrrolidine dithiocarbamate prevents cardiac remodelling and matrix metalloproteinase-2 up-regulation in renovascular hypertension [Internet]. Basic and Clinical Pharmacology and Toxicology. 2015 ; 117( 4): 234-241.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/bcpt.12400
Trabalho de evento-resumo
Atorvastatin and sildenafil improve endothelial dysfunction, inhibition pro-fibrotic factors, and increase nitrite concentrations in hypertension (2014)
Guimarães, Danielle; Rizzi, Elen; Ceron, Carla; Pinheiro, Lucas C.; Martins-Oliveira, Alisson; Gerlach, Raquel Fernanda; Tanus-Santos, José Eduardo
Source: Abstracts. Conference titles: Nitrite Oxide-Nitrite/Nitrate Conference. Unidades: FMRP, FORP
Subjects: FÁRMACOS (SISTEMA CARDIOVASCULAR), HIPERTENSÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUIMARÃES, Danielle et al. Atorvastatin and sildenafil improve endothelial dysfunction, inhibition pro-fibrotic factors, and increase nitrite concentrations in hypertension. 2014, Anais.. Cleveland: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 2014. . Acesso em: 16 nov. 2024.
APA
Guimarães, D., Rizzi, E., Ceron, C., Pinheiro, L. C., Martins-Oliveira, A., Gerlach, R. F., & Tanus-Santos, J. E. (2014). Atorvastatin and sildenafil improve endothelial dysfunction, inhibition pro-fibrotic factors, and increase nitrite concentrations in hypertension. In Abstracts. Cleveland: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Guimarães D, Rizzi E, Ceron C, Pinheiro LC, Martins-Oliveira A, Gerlach RF, Tanus-Santos JE. Atorvastatin and sildenafil improve endothelial dysfunction, inhibition pro-fibrotic factors, and increase nitrite concentrations in hypertension. Abstracts. 2014 ;[citado 2024 nov. 16 ]
Vancouver
Guimarães D, Rizzi E, Ceron C, Pinheiro LC, Martins-Oliveira A, Gerlach RF, Tanus-Santos JE. Atorvastatin and sildenafil improve endothelial dysfunction, inhibition pro-fibrotic factors, and increase nitrite concentrations in hypertension. Abstracts. 2014 ;[citado 2024 nov. 16 ]
Artigo de periodico
Antioxidant effect of doxycycline decreases MMP activity and blood pressure in SHR (2014)
Antonio, Raquel C.; Ceron, Carla S.; Rizzi, Elen; Coelho, Eduardo Barbosa; Tanus-Santos, José Eduardo; Gerlach, Raquel Fernanda
Source: Molecular and Cellular Biochemistry. Unidades: FMRP, FORP
Subjects: HIPERTENSÃO, ESTRESSE OXIDATIVO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANTONIO, Raquel C. et al. Antioxidant effect of doxycycline decreases MMP activity and blood pressure in SHR. Molecular and Cellular Biochemistry, v. 386, n. 1-2, p. 99-105, 2014Tradução . . Disponível em: https://doi.org/10.1007/s11010-013-1848-7. Acesso em: 16 nov. 2024.
APA
Antonio, R. C., Ceron, C. S., Rizzi, E., Coelho, E. B., Tanus-Santos, J. E., & Gerlach, R. F. (2014). Antioxidant effect of doxycycline decreases MMP activity and blood pressure in SHR. Molecular and Cellular Biochemistry, 386( 1-2), 99-105. doi:10.1007/s11010-013-1848-7
NLM
Antonio RC, Ceron CS, Rizzi E, Coelho EB, Tanus-Santos JE, Gerlach RF. Antioxidant effect of doxycycline decreases MMP activity and blood pressure in SHR [Internet]. Molecular and Cellular Biochemistry. 2014 ; 386( 1-2): 99-105.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s11010-013-1848-7
Vancouver
Antonio RC, Ceron CS, Rizzi E, Coelho EB, Tanus-Santos JE, Gerlach RF. Antioxidant effect of doxycycline decreases MMP activity and blood pressure in SHR [Internet]. Molecular and Cellular Biochemistry. 2014 ; 386( 1-2): 99-105.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s11010-013-1848-7
Artigo de periodico
Temporal changes in cardiac matrix metalloproteinase activity, oxidative stress, and TGF-'beta' in renovascular hypertension-induced cardiac hypertrophy (2013)
Rizzi, Elen; Ceron, Carla S.; Guimarães, Danielle A.; Prado, Cibele Maria; Rossi, Marcos Antonio; Gerlach, Raquel Fernanda; Santos, José Eduardo Tanus dos
Source: Experimental and Molecular Pathology. Unidades: FMRP, FORP
Subjects: METALOPROTEINASES, HIPERTENSÃO, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIZZI, Elen et al. Temporal changes in cardiac matrix metalloproteinase activity, oxidative stress, and TGF-'beta' in renovascular hypertension-induced cardiac hypertrophy. Experimental and Molecular Pathology, v. 94, n. 1, p. 1-9, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.yexmp.2012.10.010. Acesso em: 16 nov. 2024.
APA
Rizzi, E., Ceron, C. S., Guimarães, D. A., Prado, C. M., Rossi, M. A., Gerlach, R. F., & Santos, J. E. T. dos. (2013). Temporal changes in cardiac matrix metalloproteinase activity, oxidative stress, and TGF-'beta' in renovascular hypertension-induced cardiac hypertrophy. Experimental and Molecular Pathology, 94( 1), 1-9. doi:10.1016/j.yexmp.2012.10.010
NLM
Rizzi E, Ceron CS, Guimarães DA, Prado CM, Rossi MA, Gerlach RF, Santos JET dos. Temporal changes in cardiac matrix metalloproteinase activity, oxidative stress, and TGF-'beta' in renovascular hypertension-induced cardiac hypertrophy [Internet]. Experimental and Molecular Pathology. 2013 ; 94( 1): 1-9.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.yexmp.2012.10.010
Vancouver
Rizzi E, Ceron CS, Guimarães DA, Prado CM, Rossi MA, Gerlach RF, Santos JET dos. Temporal changes in cardiac matrix metalloproteinase activity, oxidative stress, and TGF-'beta' in renovascular hypertension-induced cardiac hypertrophy [Internet]. Experimental and Molecular Pathology. 2013 ; 94( 1): 1-9.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.yexmp.2012.10.010
Artigo de periodico
Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling (2013)
Martins-Oliveira, Alisson; Castro, Michele Mazzaron de; Oliveira, Diogo M. M.; Rizzi, Elen; Ceron, Carla S.; Guimarães, Danielle; Reis, Rosana I.; Costa Neto, Claudio Miguel da; Casarini, Dulce E.; Ribeiro, Amanda A.; Gerlach, Raquel Fernanda; Tanus-Santos, José Eduardo
Source: International Journal of Cardiology. Unidades: FMRP, FORP
Subjects: ANGIOTENSINA II, HIPERTENSÃO, METALOPROTEINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARTINS-OLIVEIRA, Alisson et al. Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling. International Journal of Cardiology, v. 167, n. 4, p. 1199-1205, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.ijcard.2012.03.137. Acesso em: 16 nov. 2024.
APA
Martins-Oliveira, A., Castro, M. M. de, Oliveira, D. M. M., Rizzi, E., Ceron, C. S., Guimarães, D., et al. (2013). Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling. International Journal of Cardiology, 167( 4), 1199-1205. doi:10.1016/j.ijcard.2012.03.137
NLM
Martins-Oliveira A, Castro MM de, Oliveira DMM, Rizzi E, Ceron CS, Guimarães D, Reis RI, Costa Neto CM da, Casarini DE, Ribeiro AA, Gerlach RF, Tanus-Santos JE. Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling [Internet]. International Journal of Cardiology. 2013 ; 167( 4): 1199-1205.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.ijcard.2012.03.137
Vancouver
Martins-Oliveira A, Castro MM de, Oliveira DMM, Rizzi E, Ceron CS, Guimarães D, Reis RI, Costa Neto CM da, Casarini DE, Ribeiro AA, Gerlach RF, Tanus-Santos JE. Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling [Internet]. International Journal of Cardiology. 2013 ; 167( 4): 1199-1205.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.ijcard.2012.03.137
Artigo de periodico
Tempol inhibits TGF-'beta' and MMPs upregulation and prevents cardiac hypertensive changes (2013)
Rizzi, Elen; Castro, Michele M.; Ceron, Carla S.; Neto-Neves, Evandro M.; Prado, Cibele Maria; Rossi, Marcos Antonio; Tanus-Santos, José Eduardo; Gerlach, Raquel Fernanda
Source: International Journal of Cardiology. Unidades: FMRP, FORP
Subjects: ESTRESSE OXIDATIVO, METALOPROTEINASES, HIPERTENSÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIZZI, Elen et al. Tempol inhibits TGF-'beta' and MMPs upregulation and prevents cardiac hypertensive changes. International Journal of Cardiology, v. 165, n. 1, p. 165-173, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.ijcard.2011.08.060. Acesso em: 16 nov. 2024.
APA
Rizzi, E., Castro, M. M., Ceron, C. S., Neto-Neves, E. M., Prado, C. M., Rossi, M. A., et al. (2013). Tempol inhibits TGF-'beta' and MMPs upregulation and prevents cardiac hypertensive changes. International Journal of Cardiology, 165( 1), 165-173. doi:10.1016/j.ijcard.2011.08.060
NLM
Rizzi E, Castro MM, Ceron CS, Neto-Neves EM, Prado CM, Rossi MA, Tanus-Santos JE, Gerlach RF. Tempol inhibits TGF-'beta' and MMPs upregulation and prevents cardiac hypertensive changes [Internet]. International Journal of Cardiology. 2013 ; 165( 1): 165-173.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.ijcard.2011.08.060
Vancouver
Rizzi E, Castro MM, Ceron CS, Neto-Neves EM, Prado CM, Rossi MA, Tanus-Santos JE, Gerlach RF. Tempol inhibits TGF-'beta' and MMPs upregulation and prevents cardiac hypertensive changes [Internet]. International Journal of Cardiology. 2013 ; 165( 1): 165-173.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.ijcard.2011.08.060
Artigo de periodico
Nebivolol attenuates prooxidant and profibrotic mechanisms involving TGF-β and MMPs, and decreases vascular remodeling in renovascular hypertension (2013)
Ceron, Carla S.; Rizzi, Elen; Guimarães, Danielle A.; Martins-Oliveira, Alisson; Gerlach, Raquel Fernanda; Tanus-Santos, José Eduardo
Source: Free Radical Biology & Medicine. Unidades: FORP, FMRP
Subjects: RECEPTORES ADRENÉRGICOS, METALOPROTEINASES, ESTRESSE OXIDATIVO, HIPERTENSÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERON, Carla S. et al. Nebivolol attenuates prooxidant and profibrotic mechanisms involving TGF-β and MMPs, and decreases vascular remodeling in renovascular hypertension. Free Radical Biology & Medicine, v. 65, p. 47-56, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.freeradbiomed.2013.06.033. Acesso em: 16 nov. 2024.
APA
Ceron, C. S., Rizzi, E., Guimarães, D. A., Martins-Oliveira, A., Gerlach, R. F., & Tanus-Santos, J. E. (2013). Nebivolol attenuates prooxidant and profibrotic mechanisms involving TGF-β and MMPs, and decreases vascular remodeling in renovascular hypertension. Free Radical Biology & Medicine, 65, 47-56. doi:10.1016/j.freeradbiomed.2013.06.033
NLM
Ceron CS, Rizzi E, Guimarães DA, Martins-Oliveira A, Gerlach RF, Tanus-Santos JE. Nebivolol attenuates prooxidant and profibrotic mechanisms involving TGF-β and MMPs, and decreases vascular remodeling in renovascular hypertension [Internet]. Free Radical Biology & Medicine. 2013 ; 65 47-56.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.freeradbiomed.2013.06.033
Vancouver
Ceron CS, Rizzi E, Guimarães DA, Martins-Oliveira A, Gerlach RF, Tanus-Santos JE. Nebivolol attenuates prooxidant and profibrotic mechanisms involving TGF-β and MMPs, and decreases vascular remodeling in renovascular hypertension [Internet]. Free Radical Biology & Medicine. 2013 ; 65 47-56.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.freeradbiomed.2013.06.033
Artigo de periodico
Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling (2013)
Martins-Oliveira, Alisson; Castro, Michele M.; Oliveira, Diogo M. M.; Rizzi, Elen; Ceron, Carla S.; Guimarães, Danielle; Reis, Rosana I.; Costa Neto, Cláudio Miguel; Casarini, Dulce E.; Ribeiro, Amanda A.; Gerlach, Raquel Fernanda; Santos, José Eduardo Tanus dos
Source: International Journal of Cardiology. Unidades: FMRP, FORP
Subjects: HIPERTENSÃO, ANGIOTENSINA II, METALOPROTEINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARTINS-OLIVEIRA, Alisson et al. Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling. International Journal of Cardiology, v. 167, n. 4, p. 1199-1205, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.ijcard.2012.03.137. Acesso em: 16 nov. 2024.
APA
Martins-Oliveira, A., Castro, M. M., Oliveira, D. M. M., Rizzi, E., Ceron, C. S., Guimarães, D., et al. (2013). Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling. International Journal of Cardiology, 167( 4), 1199-1205. doi:10.1016/j.ijcard.2012.03.137
NLM
Martins-Oliveira A, Castro MM, Oliveira DMM, Rizzi E, Ceron CS, Guimarães D, Reis RI, Costa Neto CM, Casarini DE, Ribeiro AA, Gerlach RF, Santos JET dos. Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling [Internet]. International Journal of Cardiology. 2013 ; 167( 4): 1199-1205.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.ijcard.2012.03.137
Vancouver
Martins-Oliveira A, Castro MM, Oliveira DMM, Rizzi E, Ceron CS, Guimarães D, Reis RI, Costa Neto CM, Casarini DE, Ribeiro AA, Gerlach RF, Santos JET dos. Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling [Internet]. International Journal of Cardiology. 2013 ; 167( 4): 1199-1205.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.ijcard.2012.03.137
Trabalho de evento-resumo
Chronic treatment with nebivolol attenuates the vascular changes in the 2-kidney, 1-clip model of renovascular hypertension (2012)
Ceron, Carla S.; Rizzi, Elen; Guimarães, Danielle A.; Martins-Oliveira, Alisson; Gerlach, Raquel Fernanda; Tanus-Santos, José Eduardo
Source: Final Program. Conference titles: High Blood Pressure Research Scientific Sessions (HBPR). Unidades: FMRP, FORP
Subjects: HIPERTENSÃO, RECEPTORES DE ANGIOTENSINA, ESTRESSE OXIDATIVO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERON, Carla S. et al. Chronic treatment with nebivolol attenuates the vascular changes in the 2-kidney, 1-clip model of renovascular hypertension. 2012, Anais.. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 2012. . Acesso em: 16 nov. 2024.
APA
Ceron, C. S., Rizzi, E., Guimarães, D. A., Martins-Oliveira, A., Gerlach, R. F., & Tanus-Santos, J. E. (2012). Chronic treatment with nebivolol attenuates the vascular changes in the 2-kidney, 1-clip model of renovascular hypertension. In Final Program. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Ceron CS, Rizzi E, Guimarães DA, Martins-Oliveira A, Gerlach RF, Tanus-Santos JE. Chronic treatment with nebivolol attenuates the vascular changes in the 2-kidney, 1-clip model of renovascular hypertension. Final Program. 2012 ;[citado 2024 nov. 16 ]
Vancouver
Ceron CS, Rizzi E, Guimarães DA, Martins-Oliveira A, Gerlach RF, Tanus-Santos JE. Chronic treatment with nebivolol attenuates the vascular changes in the 2-kidney, 1-clip model of renovascular hypertension. Final Program. 2012 ;[citado 2024 nov. 16 ]
Trabalho de evento-resumo
Exposição a altas concentrações de chumbo promove hipertensão e disfunção endotelial em aorta de ratos (2012)
Rizzi, E.; Alves, F. H. F.; Moraes, Leonardo Resstel Barbosa; Corrêa, Fernando Morgan de Aguiar; Bendhack, Lusiane Maria; Gerlach, Raquel Fernanda; Tanus-Santos, José Eduardo
Source: Programa Científico. Conference titles: Simpósio em Biologia Vascular. Unidades: FCFRP, FORP, FMRP
Subjects: CHUMBO, HIPERTENSÃO, ENDOTÉLIO VASCULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIZZI, E. et al. Exposição a altas concentrações de chumbo promove hipertensão e disfunção endotelial em aorta de ratos. 2012, Anais.. Ribeirão Preto: FCFRP-USP, 2012. . Acesso em: 16 nov. 2024.
APA
Rizzi, E., Alves, F. H. F., Moraes, L. R. B., Corrêa, F. M. de A., Bendhack, L. M., Gerlach, R. F., & Tanus-Santos, J. E. (2012). Exposição a altas concentrações de chumbo promove hipertensão e disfunção endotelial em aorta de ratos. In Programa Científico. Ribeirão Preto: FCFRP-USP.
NLM
Rizzi E, Alves FHF, Moraes LRB, Corrêa FM de A, Bendhack LM, Gerlach RF, Tanus-Santos JE. Exposição a altas concentrações de chumbo promove hipertensão e disfunção endotelial em aorta de ratos. Programa Científico. 2012 ;[citado 2024 nov. 16 ]
Vancouver
Rizzi E, Alves FHF, Moraes LRB, Corrêa FM de A, Bendhack LM, Gerlach RF, Tanus-Santos JE. Exposição a altas concentrações de chumbo promove hipertensão e disfunção endotelial em aorta de ratos. Programa Científico. 2012 ;[citado 2024 nov. 16 ]
Artigo de periodico
Comprehensive evaluation of the effects of enalapril on matrix metalloproteinases levels in hypertension (2012)
Fontana, Vanessa; Silva, Pamela S.; Izidoro-Toledo, Tatiane C.; Biagi, Celso; Oliveira, Eduardo Brandt de; Gerlach, Raquel Fernanda; Tanus-Santos, José Eduardo
Source: Cardiovascular Drugs and Therapy. Unidades: FMRP, FORP
Subjects: ANGIOTENSINAS, METALOPROTEINASES, HIPERTENSÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FONTANA, Vanessa et al. Comprehensive evaluation of the effects of enalapril on matrix metalloproteinases levels in hypertension. Cardiovascular Drugs and Therapy, v. 26, n. 6, p. 511-519, 2012Tradução . . Disponível em: https://doi.org/10.1007/s10557-012-6420-2. Acesso em: 16 nov. 2024.
APA
Fontana, V., Silva, P. S., Izidoro-Toledo, T. C., Biagi, C., Oliveira, E. B. de, Gerlach, R. F., & Tanus-Santos, J. E. (2012). Comprehensive evaluation of the effects of enalapril on matrix metalloproteinases levels in hypertension. Cardiovascular Drugs and Therapy, 26( 6), 511-519. doi:10.1007/s10557-012-6420-2
NLM
Fontana V, Silva PS, Izidoro-Toledo TC, Biagi C, Oliveira EB de, Gerlach RF, Tanus-Santos JE. Comprehensive evaluation of the effects of enalapril on matrix metalloproteinases levels in hypertension [Internet]. Cardiovascular Drugs and Therapy. 2012 ; 26( 6): 511-519.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s10557-012-6420-2
Vancouver
Fontana V, Silva PS, Izidoro-Toledo TC, Biagi C, Oliveira EB de, Gerlach RF, Tanus-Santos JE. Comprehensive evaluation of the effects of enalapril on matrix metalloproteinases levels in hypertension [Internet]. Cardiovascular Drugs and Therapy. 2012 ; 26( 6): 511-519.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s10557-012-6420-2
Artigo de periodico
Doxycycline ameliorates 2K-1C hypertension-induced vascular dysfunction in rats by attenuating oxidative stress and improving nitric oxide bioavailability (2012)
Castro, Michele M.; Rizzi, Elen; Ceron, Carla S.; Guimarães, Danielle A.; Rodrigues, Gerson J.; Bendhack, Lusiane Maria; Gerlach, Raquel Fernanda; Tanus-Santos, José Eduardo
Source: Nitric Oxide. Unidades: FCFRP, FORP, FMRP
Subjects: HIPERTENSÃO, FÁRMACOS (SISTEMA CARDIOVASCULAR) (EFEITOS), ESTRESSE OXIDATIVO, NEUTRÓFILOS (TESTES;TÉCNICAS IN VITRO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO, Michele M. et al. Doxycycline ameliorates 2K-1C hypertension-induced vascular dysfunction in rats by attenuating oxidative stress and improving nitric oxide bioavailability. Nitric Oxide, v. 26, n. 3, p. 162-168, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.niox.2012.01.009. Acesso em: 16 nov. 2024.
APA
Castro, M. M., Rizzi, E., Ceron, C. S., Guimarães, D. A., Rodrigues, G. J., Bendhack, L. M., et al. (2012). Doxycycline ameliorates 2K-1C hypertension-induced vascular dysfunction in rats by attenuating oxidative stress and improving nitric oxide bioavailability. Nitric Oxide, 26( 3), 162-168. doi:10.1016/j.niox.2012.01.009
NLM
Castro MM, Rizzi E, Ceron CS, Guimarães DA, Rodrigues GJ, Bendhack LM, Gerlach RF, Tanus-Santos JE. Doxycycline ameliorates 2K-1C hypertension-induced vascular dysfunction in rats by attenuating oxidative stress and improving nitric oxide bioavailability [Internet]. Nitric Oxide. 2012 ; 26( 3): 162-168.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.niox.2012.01.009
Vancouver
Castro MM, Rizzi E, Ceron CS, Guimarães DA, Rodrigues GJ, Bendhack LM, Gerlach RF, Tanus-Santos JE. Doxycycline ameliorates 2K-1C hypertension-induced vascular dysfunction in rats by attenuating oxidative stress and improving nitric oxide bioavailability [Internet]. Nitric Oxide. 2012 ; 26( 3): 162-168.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.niox.2012.01.009
Trabalho de evento-resumo
Atorvastatin and sildenafil reduce vascular remodeling and oxidative stress in 2K1C-hypertension (2012)
Guimarães, Danielle A.; Rizzi, Elen; Ceron, Carla; Martins-Oliveira, Alisson; Gerlach, Raquel Fernanda; Tanus-Santos, José Eduardo
Source: Final Program. Conference titles: High Blood Pressure Research Scientific Sessions (HBPR). Unidades: FMRP, FORP
Subjects: ESTRESSE OXIDATIVO, FÁRMACOS, HIPERTENSÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUIMARÃES, Danielle A. et al. Atorvastatin and sildenafil reduce vascular remodeling and oxidative stress in 2K1C-hypertension. 2012, Anais.. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 2012. . Acesso em: 16 nov. 2024.
APA
Guimarães, D. A., Rizzi, E., Ceron, C., Martins-Oliveira, A., Gerlach, R. F., & Tanus-Santos, J. E. (2012). Atorvastatin and sildenafil reduce vascular remodeling and oxidative stress in 2K1C-hypertension. In Final Program. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Guimarães DA, Rizzi E, Ceron C, Martins-Oliveira A, Gerlach RF, Tanus-Santos JE. Atorvastatin and sildenafil reduce vascular remodeling and oxidative stress in 2K1C-hypertension. Final Program. 2012 ;[citado 2024 nov. 16 ]
Vancouver
Guimarães DA, Rizzi E, Ceron C, Martins-Oliveira A, Gerlach RF, Tanus-Santos JE. Atorvastatin and sildenafil reduce vascular remodeling and oxidative stress in 2K1C-hypertension. Final Program. 2012 ;[citado 2024 nov. 16 ]
Artigo de periodico
Comparative study on antioxidant effects and vascular matrix metalloproteinase-2 downregulation by dihydropyridines in renovascular hypertension (2011)
Marçal, Diogo M. O.; Rizzi, Elen; Martins-Oliveira, Alisson; Ceron, Carla S.; Guimarães, Danielle A.; Gerlach, Raquel Fernanda; Tanus-Santos, José Eduardo
Source: Naunyn-Schmiedeberg's Archives of Pharmacology. Unidades: FORP, FMRP
Subjects: HIPERTENSÃO, ANTIOXIDANTES, METALOPROTEINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARÇAL, Diogo M. O. et al. Comparative study on antioxidant effects and vascular matrix metalloproteinase-2 downregulation by dihydropyridines in renovascular hypertension. Naunyn-Schmiedeberg's Archives of Pharmacology, v. 383, n. 1, p. 35-44, 2011Tradução . . Disponível em: https://doi.org/10.1007/s00210-010-0573-y. Acesso em: 16 nov. 2024.
APA
Marçal, D. M. O., Rizzi, E., Martins-Oliveira, A., Ceron, C. S., Guimarães, D. A., Gerlach, R. F., & Tanus-Santos, J. E. (2011). Comparative study on antioxidant effects and vascular matrix metalloproteinase-2 downregulation by dihydropyridines in renovascular hypertension. Naunyn-Schmiedeberg's Archives of Pharmacology, 383( 1), 35-44. doi:10.1007/s00210-010-0573-y
NLM
Marçal DMO, Rizzi E, Martins-Oliveira A, Ceron CS, Guimarães DA, Gerlach RF, Tanus-Santos JE. Comparative study on antioxidant effects and vascular matrix metalloproteinase-2 downregulation by dihydropyridines in renovascular hypertension [Internet]. Naunyn-Schmiedeberg's Archives of Pharmacology. 2011 ; 383( 1): 35-44.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s00210-010-0573-y
Vancouver
Marçal DMO, Rizzi E, Martins-Oliveira A, Ceron CS, Guimarães DA, Gerlach RF, Tanus-Santos JE. Comparative study on antioxidant effects and vascular matrix metalloproteinase-2 downregulation by dihydropyridines in renovascular hypertension [Internet]. Naunyn-Schmiedeberg's Archives of Pharmacology. 2011 ; 383( 1): 35-44.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s00210-010-0573-y
Artigo de periodico
Doxycycline dose-dependently inhibits MMP-2-mediated vascular changes in 2K1C hypertension (2011)
Guimarães, Danielle A.; Rizzi, Elen; Ceron, Carla S.; Oliveira, Alisson M.; Oliveira, Diogo M.; Castro, Michele M.; Tirapelli, Carlos Renato ; Gerlach, Raquel Fernanda; Tanus-Santos, José Eduardo
Source: Basic & Clinical Pharmacology & Toxicology. Unidades: FMRP, EERP, FORP
Subjects: HIPERTENSÃO, METALOPROTEINASES, FÁRMACOS (SISTEMA CARDIOVASCULAR)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUIMARÃES, Danielle A. et al. Doxycycline dose-dependently inhibits MMP-2-mediated vascular changes in 2K1C hypertension. Basic & Clinical Pharmacology & Toxicology, v. 108, n. 5, p. 318-325, 2011Tradução . . Acesso em: 16 nov. 2024.
APA
Guimarães, D. A., Rizzi, E., Ceron, C. S., Oliveira, A. M., Oliveira, D. M., Castro, M. M., et al. (2011). Doxycycline dose-dependently inhibits MMP-2-mediated vascular changes in 2K1C hypertension. Basic & Clinical Pharmacology & Toxicology, 108( 5), 318-325.
NLM
Guimarães DA, Rizzi E, Ceron CS, Oliveira AM, Oliveira DM, Castro MM, Tirapelli CR, Gerlach RF, Tanus-Santos JE. Doxycycline dose-dependently inhibits MMP-2-mediated vascular changes in 2K1C hypertension. Basic & Clinical Pharmacology & Toxicology. 2011 ; 108( 5): 318-325.[citado 2024 nov. 16 ]
Vancouver
Guimarães DA, Rizzi E, Ceron CS, Oliveira AM, Oliveira DM, Castro MM, Tirapelli CR, Gerlach RF, Tanus-Santos JE. Doxycycline dose-dependently inhibits MMP-2-mediated vascular changes in 2K1C hypertension. Basic & Clinical Pharmacology & Toxicology. 2011 ; 108( 5): 318-325.[citado 2024 nov. 16 ]
Artigo de periodico
Pyrrolidine dithiocarbamate down-regulates vascular matrix metalloproteinases and ameliorates vascular dysfunction and remodelling in renovascular hypertension (2011)
Cáu, Stêfany Bruno de Assis; Guimarães, Danielle Aparecida; Sanches, Elen Rizzi; Ceron, Carla Speroni; Souza, L. L.; Tirapelli, Carlos Renato ; Gerlach, Raquel Fernanda; Santos, José Eduardo Tanus dos
Source: British Journal Pharmacology. Unidades: EERP, FORP, FMRP
Subjects: METALOPROTEINASES, HIPERTENSÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CÁU, Stêfany Bruno de Assis et al. Pyrrolidine dithiocarbamate down-regulates vascular matrix metalloproteinases and ameliorates vascular dysfunction and remodelling in renovascular hypertension. British Journal Pharmacology, v. 164, n. 2, p. 372-381, 2011Tradução . . Acesso em: 16 nov. 2024.
APA
Cáu, S. B. de A., Guimarães, D. A., Sanches, E. R., Ceron, C. S., Souza, L. L., Tirapelli, C. R., et al. (2011). Pyrrolidine dithiocarbamate down-regulates vascular matrix metalloproteinases and ameliorates vascular dysfunction and remodelling in renovascular hypertension. British Journal Pharmacology, 164( 2), 372-381.
NLM
Cáu SB de A, Guimarães DA, Sanches ER, Ceron CS, Souza LL, Tirapelli CR, Gerlach RF, Santos JET dos. Pyrrolidine dithiocarbamate down-regulates vascular matrix metalloproteinases and ameliorates vascular dysfunction and remodelling in renovascular hypertension. British Journal Pharmacology. 2011 ; 164( 2): 372-381.[citado 2024 nov. 16 ]
Vancouver
Cáu SB de A, Guimarães DA, Sanches ER, Ceron CS, Souza LL, Tirapelli CR, Gerlach RF, Santos JET dos. Pyrrolidine dithiocarbamate down-regulates vascular matrix metalloproteinases and ameliorates vascular dysfunction and remodelling in renovascular hypertension. British Journal Pharmacology. 2011 ; 164( 2): 372-381.[citado 2024 nov. 16 ]

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Conference titles

Countries/Territories

Funding Agencies

Indexado em